AXIN2 and acute myeloid leukemia: RNA-seq analysis showed that WNT6, WNT7B, FZD2, PRICKLE1 and CELSR1 were significantly upregulated in AML patients; while WNT signaling inhibitors, such as AXIN2 [25], were downregulated (Fig. 1).